Assessing the therapeutic role of trehalose and hyaluronic acid: implications for patient care.

Autor: Gawash A; American Preventive Screening & Education Association (APSEA), 121 East Laurel Rd, Stratford, NJ, 08084, UK. EonPublishing@gmail.com.; Department of Biology, The State University of New Jersey, Rutgers, New Brunswick, NJ, USA. EonPublishing@gmail.com., Simonetti A; American Preventive Screening & Education Association (APSEA), 121 East Laurel Rd, Stratford, NJ, 08084, UK., Lo DF; American Preventive Screening & Education Association (APSEA), 121 East Laurel Rd, Stratford, NJ, 08084, UK.; Department of Biology, The State University of New Jersey, Rutgers, New Brunswick, NJ, USA., Shamilov DD; American Preventive Screening & Education Association (APSEA), 121 East Laurel Rd, Stratford, NJ, 08084, UK., Kumar A; Department of Ophthalmology, Westchester Medical Center, New York Medical College, Valhalla, NY, USA., Wong JC; Department of Ophthalmology, Westchester Medical Center, New York Medical College, Valhalla, NY, USA.
Jazyk: angličtina
Zdroj: International ophthalmology [Int Ophthalmol] 2024 Oct 01; Vol. 44 (1), pp. 398. Date of Electronic Publication: 2024 Oct 01.
DOI: 10.1007/s10792-024-03308-1
Abstrakt: Objective: This Systematic review aims to assess the efficacy of trehalose and hyaluronic acid in enhancing ocular recovery post-cataract surgery, focusing on their impact on tear film stability, ocular surface integrity, and patient-reported outcomes.
Methods: A comprehensive search was conducted across MEDLINE, PubMed, and Cochrane Library databases to identify randomized controlled trials investigating the efficacy of trehalose, hyaluronic acid, or their combination in post-cataract surgery care. The inclusion criteria focused on peer-reviewed studies in English, detailing outcomes relevant to ocular recovery such as tear film stability, ocular surface integrity, patient-reported discomfort, or visual acuity (VA). The quality of the included studies was assessed using the Cochrane Risk of Bias Tool and synthesized the data qualitatively.
Results: Four qualitative investigations met the inclusion criteria. The studies collectively assessed the efficacy of a 3% trehalose and 0.15% hyaluronic acid eye drop solution in reducing postoperative eye symptoms compared to various control solutions. Parameters measured included tear break-up time (TBUT), Fluorescein staining, tear production (Schirmer test), and Ocular Surface Disease Index (OSDI) scores. The results indicated significant improvements in tear film stability and ocular surface health for the treatment groups compared to controls, with a notable decrease in patient-reported discomfort. The study showed an improvement of - 18 (± 14.6) in the treatment group compared to - 7 (± 8.0) in the control group for OSDI. For TBUT, the treatment group improved by 3 (± 1.2) s, whereas the control group improved by 0.3 (± 0.71) s. VA, measured on a scale of 0-100, increased to 17 (± 0.7) in the treatment group compared to 15 (± 1.1) in the control group.
Conclusions: Trehalose and hyaluronic acid may be beneficial in the postoperative period by enhancing tear film stability and ocular surface health. While the results are promising, further research is needed to confirm these findings, understand the mechanisms of action, and explore broader applications.
(© 2024. The Author(s), under exclusive licence to Springer Nature B.V.)
Databáze: MEDLINE
Externí odkaz: